GSTM1 and colorectal carcinoma: Our Cox model at both a 1% or 3% threshold of CRC risk would offer additional improvements in false negative and false positive rates compared to the equivalent f‐Hb ≥ 10 μg/g or f‐Hb ≥ 40 μg/g thresholds.